[Vaccination of immunocompromised patients: when and when not to vaccinate]

Ned Tijdschr Geneeskd. 2020 Sep 3:164:D5299.
[Article in Dutch]

Abstract

Immunocompromised individuals are at increased risk of infectious diseases and their complications. The main examples of these are pneumococcal disease and influenza, infections that are both vaccine-preventable. However, responses to vaccination are often impaired in immunocompromised patients. In addition, live-attenuated vaccines, including the measles-mumps-rubella and yellow fever vaccine, cannot be administered to these patients for safety reasons. In view of the decreasing herd immunity caused by a drop in global vaccination coverage, immunocompromised individuals are at increased risk of infections such as measles, especially during travel abroad. Despite these developments, the improved quality of life resulting from novel treatment options means that immunocompromised patients are travelling more and further than ever. It is the responsibility of the treating physician of the immunocompromised individual to ensure that all the required vaccines are provided in time. To this end, the physician may also refer the patient to the general practitioner or travel clinic for the actual vaccination.

MeSH terms

  • Female
  • Humans
  • Immunocompromised Host*
  • Measles-Mumps-Rubella Vaccine / adverse effects
  • Middle Aged
  • Travel*
  • Vaccines, Attenuated* / adverse effects
  • Yellow Fever Vaccine / adverse effects
  • Young Adult

Substances

  • Measles-Mumps-Rubella Vaccine
  • Vaccines, Attenuated
  • Yellow Fever Vaccine